Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Patient-reported healthcare expectations in inflammatory bowel diseases.

Pittet V, Vaucher C, Froehlich F, Maillard MH, Michetti P; Swiss IBD Cohort Study Group.

PLoS One. 2018 May 17;13(5):e0197351. doi: 10.1371/journal.pone.0197351. eCollection 2018.

2.

Superficial Chronic Ulcerative Dermatitis (SCUD) in Psittacine Birds: Review of 11 Cases (2008-2016).

Abou-Zahr T, Carrasco DC, Dvm NS, Forbes NA, Dutton TAG, Froehlich F, De Bellis F.

J Avian Med Surg. 2018 Mar;32(1):25-33. doi: 10.1647/2017-250.

PMID:
29698080
3.

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.

Vavricka SR, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N, Juillerat P, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Heinrich H, Manser CN, Safroneeva E, Raja Ali RA, Rogler G, Schoepfer AM, Greuter T; Swiss IBD Cohort Study Group.

Inflamm Bowel Dis. 2017 Jul;23(7):1174-1181. doi: 10.1097/MIB.0000000000001109.

4.

Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicator.

Pittet V, Vaucher C, Froehlich F, Burnand B, Michetti P, Maillard MH; Swiss IBD Cohort Study Group.

PLoS One. 2017 Feb 10;12(2):e0171864. doi: 10.1371/journal.pone.0171864. eCollection 2017.

5.

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.

Greuter T, Bertoldo F, Rechner R, Straumann A, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Rogler G, Safroneeva E, Ali RAR, Braegger C, Heyland K, Mueller P, Nydegger A, Petit LM, Schibli S, Furlano RI, Spalinger J, Schäppi M, Zamora S, Froehlich F, Herzog D, Schoepfer AM, Vavricka SR; Swiss IBD Cohort Study Group.

J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):200-206. doi: 10.1097/MPG.0000000000001455.

6.

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.

Mottet C, Schoepfer AM, Juillerat P, Cosnes J, Froehlich F, Kessler-Brondolo V, Seibold F, Rogler G, Vavricka SR, Michetti P.

Inflamm Bowel Dis. 2016 Nov;22(11):2733-2747.

7.

Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?

Vaucher C, Maillard MH, Froehlich F, Burnand B, Michetti P, Pittet V.

Scand J Gastroenterol. 2016 Sep;51(9):1056-61. doi: 10.3109/00365521.2016.1147065. Epub 2016 Feb 19.

PMID:
26891800
8.

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.

Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM.

Inflamm Bowel Dis. 2015 Aug;21(8):1794-800. doi: 10.1097/MIB.0000000000000429.

9.

Aqueous black colloids of reticular nanostructured gold.

Stanca SE, Fritzsche W, Dellith J, Froehlich F, Undisz A, Deckert V, Krafft C, Popp J.

Sci Rep. 2015 Jan 20;5:7899. doi: 10.1038/srep07899.

10.

Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts?

Pittet V, Maillard MH, Lauvergeon S, Timmer M, Michetti P, Froehlich F, Burnand B, Vader JP, Mottet C.

J Crohns Colitis. 2015 Feb;9(2):132-9.

PMID:
25518062
11.

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR.

Inflamm Bowel Dis. 2015 Jan;21(1):60-70. doi: 10.1097/MIB.0000000000000225.

PMID:
25517594
12.

The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.

Schoepfer AM, Bortolotti M, Pittet V, Mottet C, Gonvers JJ, Reich O, Fournier N, Vader JP, Burnand B, Michetti P, Froehlich F.

Aliment Pharmacol Ther. 2014 Oct;40(8):930-7. doi: 10.1111/apt.12929. Epub 2014 Aug 22.

13.

IR spectroscopic methods for the investigation of the CO release from CORMs.

Klein M, Neugebauer U, Gheisari A, Malassa A, Jazzazi TM, Froehlich F, Westerhausen M, Schmitt M, Popp J.

J Phys Chem A. 2014 Jul 24;118(29):5381-90. doi: 10.1021/jp503407u. Epub 2014 Jul 10.

PMID:
24978105
14.

Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness.

Burri E, Manz M, Schroeder P, Froehlich F, Rossi L, Beglinger C, Lehmann FS.

BMC Gastroenterol. 2014 Mar 29;14:57. doi: 10.1186/1471-230X-14-57.

15.

Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients.

Pittet V, Rogler G, Mottet C, Froehlich F, Michetti P, de Saussure P, Burnand B, Vader JP; Swiss IBD Cohort Study Group.

Scand J Gastroenterol. 2014 Jun;49(6):662-73. doi: 10.3109/00365521.2014.896408. Epub 2014 Mar 12.

16.

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis.

Maillard MH, Bortolotti M, Vader JP, Mottet C, Schoepfer A, Gonvers JJ, Burnand B, Froehlich F, Michetti P, Pittet V; Swiss IBD Cohort Study Group.

J Crohns Colitis. 2014 Aug;8(8):825-34. doi: 10.1016/j.crohns.2013.12.026. Epub 2014 Jan 22.

PMID:
24462322
17.

Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.

Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F; Swiss Inflammatory Bowel Disease Cohort Study Group.

Digestion. 2013;87(3):212-21. doi: 10.1159/000350954. Epub 2013 May 23.

18.

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.

Pittet V, Froehlich F, Maillard MH, Mottet C, Gonvers JJ, Felley C, Vader JP, Burnand B, Michetti P, Schoepfer A; EPACT-II Update Panellists.

J Crohns Colitis. 2013 Nov;7(10):820-6. doi: 10.1016/j.crohns.2013.04.013. Epub 2013 May 9.

PMID:
23664620
19.

The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM.

Sci Signal. 2012 Jun 12;5(228):ra42. doi: 10.1126/scisignal.2002790.

20.

Nonanesthesiologist-administered propofol sedation: from the exception to standard practice. Sedation and monitoring trends over 20 years.

Heuss LT, Froehlich F, Beglinger C.

Endoscopy. 2012 May;44(5):504-11. doi: 10.1055/s-0031-1291668. Epub 2012 Mar 2.

PMID:
22389232
21.

Is cold biopsy forceps resection of diminutive polyps really so inadequate?

Froehlich F.

Endoscopy. 2011 Nov;43(11):1015; author reply 1016. doi: 10.1055/s-0030-1256745. Epub 2011 Nov 4. No abstract available.

PMID:
22057768
22.

Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.

Mottet C, Vader JP, Felley C, Froehlich F, Gonvers JJ, Juillerat P, Stockbrügger R, Angelucci E, Seibold F, Michetti P, Pittet V; EPACT II Study Group.

J Crohns Colitis. 2009 Dec;3(4):257-63. doi: 10.1016/j.crohns.2009.03.008. Epub 2009 May 14.

PMID:
21172284
23.

Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II.

Felley C, Vader JP, Juillerat P, Pittet V, O'Morain C, Panis Y, Vucelic B, Gonvers JJ, Mottet C, Froehlich F, Michetti P; EPACT II Study Group.

J Crohns Colitis. 2009 Dec;3(4):250-6. doi: 10.1016/j.crohns.2009.06.001. Epub 2009 Aug 22.

PMID:
21172283
24.

Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.

Juillerat P, Vader JP, Felley C, Pittet V, Gonvers JJ, Mottet C, Bemelman WA, Lémann M, Oresland T, Michetti P, Froehlich F; EPACT II Study Group.

J Crohns Colitis. 2009 Dec;3(4):241-9. doi: 10.1016/j.crohns.2009.05.002. Epub 2009 Jul 14.

PMID:
21172282
25.

Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II.

Michetti P, Stelle M, Juillerat P, Gassull M, Heil FJ, Stange E, Mottet C, Gonvers JJ, Pittet V, Vader JP, Froehlich F, Felley C; EPACT II Study Group.

J Crohns Colitis. 2009 Dec;3(4):232-40. doi: 10.1016/j.crohns.2009.05.003. Epub 2009 Jul 15.

PMID:
21172281
26.

Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.

Juillerat P, Pittet V, Vader JP, Burnand B, Gonvers JJ, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F; Swiss IBD Cohort Study Group.

Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1352-7. Erratum in: Eur J Gastroenterol Hepatol. 2011 Mar;23(3):294. Tempia-Caliera, Michela [corrected to Schäppi, Michela].

PMID:
20964261
27.

Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.

Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F; Swiss IBD Cohort Study Group.

Aliment Pharmacol Ther. 2010 Oct;32(8):1007-16. doi: 10.1111/j.1365-2036.2010.04434.x. Epub 2010 Aug 18.

28.

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort.

Juillerat P, Pittet V, Mottet C, Felley C, Gonvers JJ, Vader JP, Burnand B, Froehlich F, Wolters FL, Stockbrügger RW, Michetti P; EC-IBD Group.

Scand J Gastroenterol. 2010 Dec;45(12):1449-56. doi: 10.3109/00365521.2010.505660. Epub 2010 Jul 26.

PMID:
20653489
29.

The effect of nonmedical factors on variations in the performance of colonoscopy among different health care settings.

Lamiraud K, Holly A, Burnand B, Juillerat P, Wietlisbach V, Froehlich F, Gonvers JJ, Vader JP.

Med Care. 2010 Feb;48(2):101-9. doi: 10.1097/MLR.0b013e3181c160ee.

PMID:
20068487
30.

Appropriateness of colonoscopy in Europe (EPAGE II). Presentation of methodology, general results, and analysis of complications.

Juillerat P, Peytremann-Bridevaux I, Vader JP, Arditi C, Schusselé Filliettaz S, Dubois RW, Gonvers JJ, Froehlich F, Burnand B, Pittet V.

Endoscopy. 2009 Mar;41(3):240-6. doi: 10.1055/s-0028-1119643. Epub 2009 Mar 11. Review.

PMID:
19280536
31.

Appropriateness of colonoscopy in Europe (EPAGE II). Functional bowel disorders: pain, constipation and bloating.

Schusselé Filliettaz S, Gonvers JJ, Peytremann-Bridevaux I, Arditi C, Delvaux M, Numans ME, Lorenzo-Zúñiga V, Dubois RW, Juillerat P, Burnand B, Pittet V, Vader JP, Froehlich F; EPAGE II Study Group.

Endoscopy. 2009 Mar;41(3):234-9. doi: 10.1055/s-0028-1119625. Epub 2009 Mar 11. Review.

PMID:
19280535
32.

Appropriateness of colonoscopy in Europe (EPAGE II). Iron-deficiency anemia and hematochezia.

Peytremann-Bridevaux I, Arditi C, Froehlich F, O'Malley J, Fairclough P, Le Moine O, Dubois RW, Gonvers JJ, Schusselé Filliettaz S, Vader JP, Juillerat P, Pittet V, Burnand B; EPAGE II Study Group.

Endoscopy. 2009 Mar;41(3):227-33. doi: 10.1055/s-0028-1119644. Epub 2009 Mar 11. Review.

PMID:
19280534
33.

Appropriateness of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease.

Schusselé Filliettaz S, Juillerat P, Burnand B, Arditi C, Windsor A, Beglinger C, Dubois RW, Peytremann-Bridevaux I, Pittet V, Gonvers JJ, Froehlich F, Vader JP; EPAGE II Study Group.

Endoscopy. 2009 Mar;41(3):218-26. doi: 10.1055/s-0028-1119627. Epub 2009 Mar 11. Review.

PMID:
19280533
34.

Appropriateness of colonoscopy in Europe (EPAGE II). Surveillance after polypectomy and after resection of colorectal cancer.

Arditi C, Gonvers JJ, Burnand B, Minoli G, Oertli D, Lacaine F, Dubois RW, Vader JP, Schusselé Filliettaz S, Peytremann-Bridevaux I, Pittet V, Juillerat P, Froehlich F; EPAGE II Study Group.

Endoscopy. 2009 Mar;41(3):209-17. doi: 10.1055/s-0028-1119646. Epub 2009 Mar 11. Review.

PMID:
19280532
35.

Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer.

Arditi C, Peytremann-Bridevaux I, Burnand B, Eckardt VF, Bytzer P, Agréus L, Dubois RW, Vader JP, Froehlich F, Pittet V, Schusselé Filliettaz S, Juillerat P, Gonvers JJ; EPAGE II Study Group.

Endoscopy. 2009 Mar;41(3):200-8. doi: 10.1055/s-0028-1119626. Epub 2009 Mar 11. Review.

PMID:
19280531
36.

Colorectal cancer detection: how well do appropriateness criteria perform?

Gonvers JJ, Burnand B, Vader JP, Froehlich F.

Clin Gastroenterol Hepatol. 2009 Jul;7(7):807-8; author reply 808. doi: 10.1016/j.cgh.2009.02.013. Epub 2009 Feb 24. No abstract available.

PMID:
19245855
37.

Propofol sedation during endoscopic procedures in private practice: the case for capnography to make 1-nurse endoscopy acceptable.

Froehlich F, Milliet N.

Gastrointest Endosc. 2008 May;67(6):1008. doi: 10.1016/j.gie.2007.12.034. No abstract available.

PMID:
18440392
38.

Drug safety in Crohn's disease therapy.

Juillerat P, Pittet V, Felley C, Mottet C, Froehlich F, Vader JP, Gonvers JJ, Michetti P.

Digestion. 2007;76(2):161-8. doi: 10.1159/000111031. Epub 2008 Feb 7. Review.

PMID:
18239408
39.

Pregnancy and breastfeeding in patients with Crohn's disease.

Mottet C, Juillerat P, Pittet V, Gonvers JJ, Froehlich F, Vader JP, Michetti P, Felley C.

Digestion. 2007;76(2):149-60. doi: 10.1159/000111030. Epub 2008 Feb 7. Review.

PMID:
18239407
40.

Extraintestinal manifestations of Crohn's disease.

Juillerat P, Mottet C, Pittet V, Froehlich F, Felley C, Gonvers JJ, Vader JP, Michetti P.

Digestion. 2007;76(2):141-8. doi: 10.1159/000111029. Epub 2008 Feb 7. Review.

PMID:
18239406
41.

Upper gastrointestinal Crohn's disease.

Mottet C, Juillerat P, Pittet V, Gonvers JJ, Michetti P, Vader JP, Felley C, Froehlich F.

Digestion. 2007;76(2):136-40. doi: 10.1159/000111028. Epub 2008 Feb 7. Review.

PMID:
18239405
42.

Maintenance of surgically induced remission of Crohn's disease.

Froehlich F, Juillerat P, Pittet V, Felley C, Mottet C, Vader JP, Michetti P, Gonvers JJ.

Digestion. 2007;76(2):130-5. doi: 10.1159/000111027. Epub 2008 Feb 7. Review.

PMID:
18239404
43.

Maintenance of medically induced remission of Crohn's disease.

Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F.

Digestion. 2007;76(2):116-29. doi: 10.1159/000111026. Epub 2008 Feb 7. Review.

PMID:
18239403
44.

Fibrostenotic Crohn's disease.

Froehlich F, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Gonvers JJ, Michetti P.

Digestion. 2007;76(2):113-5. doi: 10.1159/000111025. Epub 2008 Feb 7. Review.

PMID:
18239402
45.

Fistulizing Crohn's disease.

Felley C, Mottet C, Juillerat P, Pittet V, Froehlich F, Vader JP, Michetti P, Gonvers JJ.

Digestion. 2007;76(2):109-12. doi: 10.1159/000111024. Epub 2008 Feb 7. Review.

PMID:
18239401
46.

Severe and steroid-resistant Crohn's disease.

Michetti P, Mottet C, Juillerat P, Pittet V, Felley C, Vader JP, Gonvers JJ, Froehlich F.

Digestion. 2007;76(2):99-108. doi: 10.1159/000111023. Epub 2008 Feb 7. Review.

PMID:
18239400
47.

Mild-to-moderate active luminal Crohn's disease.

Michetti P, Juillerat P, Mottet C, Pittet V, Gonvers JJ, Vader JP, Froehlich F, Felley C.

Digestion. 2007;76(2):92-8. doi: 10.1159/000111022. Epub 2008 Feb 7. Review.

PMID:
18239399
48.

EPACT II: project and methods.

Juillerat P, Froehlich F, Felley C, Pittet V, Mottet C, Gonvers JJ, Michetti P, Vader JP.

Digestion. 2007;76(2):84-91. doi: 10.1159/000111021. Epub 2008 Feb 7.

PMID:
18239398
49.

A European view of diagnostic yield and appropriateness of colonoscopy.

Gonvers JJ, Harris JK, Wietlisbach V, Burnand B, Vader JP, Froehlich F; EPAGE Study Group.

Hepatogastroenterology. 2007 Apr-May;54(75):729-35.

PMID:
17591050
50.

Factors associated with the technical performance of colonoscopy: An EPAGE Study.

Harris JK, Froehlich F, Wietlisbach V, Burnand B, Gonvers JJ, Vader JP.

Dig Liver Dis. 2007 Jul;39(7):678-89. Epub 2007 Apr 16.

PMID:
17434349

Supplemental Content

Loading ...
Support Center